SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000904454-19-000069
Filing Date
2019-01-22
Accepted
2019-01-22 11:28:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G-A FOR ALDEYRA THERAPEUTICS, INC. BY JOHNSON & JOHNSON s13ga_012119-aldeyra.htm SC 13G/A 57984
  Complete submission text file 0000904454-19-000069.txt   59747
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88182 | Film No.: 19534752
SIC: 2834 Pharmaceutical Preparations